Kefeng Ding
Second Affiliated Hospital, Zhejiang University, School of Medicine · Department of Colorectal Surgery, The Second Hospital of Zhejiang University School of Medicine · Zhejiang University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Kefeng Ding as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:37 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07789210 · A Single-Arm, Phase II, Multicenter Clinical Study of Neoadjuvant Encorafenib Plus Cetuximab N01 and mFOLFOX6 in Patients With Locally Advanced BRAF V600E-Mutant Colorectal Cancer With or Without Resectable MetastasesZhejiang University · recruiting · Colorectal Cancer, BRAF V600E Mutation Positive, Encorafenib · principal investigator
- Ph3NCT07722494 · IBI363 Combined With Bevacizumab for Advanced Colorectal CancerInnovent Biologics (Suzhou) Co. Ltd. · recruiting · Colorectal Cancer · principal investigator
- Ph2NCT07581912 · Neoadjuvant Treatment of Fulzerasib Plus Cetuximab N01 in KRAS G12C Mutated Locally Advanced Colorectal Cancer With or Without Resectable MetastasesZhejiang University · recruiting · Colorectal Cancer, KRAS G12C Mutant Advanced Solid Tumors, Fulzerasib · principal investigator
- N/ANCT07307547 · Effectiveness of Artificial Intelligence-Assisted Colonoscopy for Adenoma Detection in Routine Clinical Practice : a Prospective Multicenter Randomized TrialZhejiang University · not yet recruiting · Colorectal Neoplasms, Colonic Polyp, Adenoma · study chair
- Ph2NCT07257653 · The Safety and Efficacy of Cetuximab Beta Plus Fruquintinib With or Without Immune Checkpoint Inhibitorrs in First-line Treatment of RAS/BRAF Wild Type Unresectable Metastatic Colorectal CancerZhejiang University · recruiting · Colorectal Neoplasms, RAS, BRAF · principal investigator
- N/ANCT06822413 · Raman Spectroscopy-Based Deep Learning Model for Early Pan-Cancer Early DiagnosisSecond Affiliated Hospital, Zhejiang University, School of Medicine · recruiting · Cancer Diagnosis, Liver Cancer, Adult, Cancer Screening · study chair
- N/ANCT06220617 · Multi-omics Study for Early Detection of Colorectal Cancer (MOED-CRC)Zhejiang University · recruiting · Colorectal Cancer, Adenomatous Polyps, Adenoma · principal investigator
- N/ANCT05923255 · LISH Trial for the Hepatic Flexure and Proximal Transverse Colon CancerZhejiang University · recruiting · Hepatic Flexure Colon Cancer, Proximal Transverse Colon Cancer · principal investigator
- Ph3NCT05699746 · CAPEOX vs Observation in Colorectal Cancer Patients With Positive MRDZhejiang University · not yet recruiting · Colorectal Cancer · principal investigator
- N/ANCT05536089 · ctDNA Methylation Application in Postoperative Relapse and Adjuvant Chemotherapy Efficacy EvaluationSinglera Genomics Inc. · recruiting · Cancer Colorectal · study director
- N/ANCT04479111 · Laparoscopic IIeocecus-Sparing Right Hemicolectomy for Cancer of the Hepatic Flexure and Proximal Transverse ColonZhejiang University · completed · Hepatic Flexure Colon Cancer, Proximal Transverse Colon Cancer · principal investigator
- N/ANCT04287335 · Multitarget Stool FIT-DNA Study for Colorectal Cancer Early Screening in ChinaZhejiang University · completed · Colorectal Cancer, Adenomatous Polyps, Adenoma · principal investigator
- N/ANCT04069455 · ePRO for Adjuvant Therapy of Colorectal AdenocarcinomaZhejiang University · unknown · Colorectal Carcinoma · principal investigator
- N/ANCT02179489 · Surgery With HIPEC in Treating Patients With a High Risk of Developing Colorectal Peritoneal CarcinomatosisZhejiang University · completed · Malignant Neoplasm of Large Intestine TNM Staging Primary Tumor (T) T4, Peritoneal Carcinomatosis · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:37 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name in colorectal cancer, ranked by citations from NIH iCite, fetched 2026-11-12 10:37 UTC. The ranking covers the 200 most relevant of 21 PubMed records, and a shared surname and initials can bring in a namesake. All 21 on PubMed
- 150 citationsRCR 11.7
- Neoadjuvant Chemotherapy With Oxaliplatin and Fluoropyrimidine Versus Upfront Surgery for Locally Advanced Colon Cancer: The Randomized, Phase III OPTICAL Trial.J Clin Oncol · 202476 citationsRCR 8.5
- Comparison of Colonoscopy, Fecal Immunochemical Test, and Risk-Adapted Approach in a Colorectal Cancer Screening Trial (TARGET-C).Clin Gastroenterol Hepatol · 202360 citationsRCR 4.9
- Extent of Lymphadenectomy for Surgical Management of Right-Sided Colon Cancer: The Randomized Phase III RELARC Trial.J Clin Oncol · 202453 citationsRCR 9.0
- Famitinib versus placebo in the treatment of refractory metastatic colorectal cancer: a multicenter, randomized, double-blinded, placebo-controlled, phase II clinical trial.Chin J Cancer · 201735 citationsRCR 1.0
- Aspirin after completion of standard adjuvant therapy for colorectal cancer (ASCOLT): an international, multicentre, phase 3, randomised, double-blind, placebo-controlled trial.Lancet Gastroenterol Hepatol · 202529 citationsRCR 7.1
- Laparoscopy-assisted versus open surgery for low rectal cancer (LASRE): 3-year survival outcomes of a multicentre, randomised, controlled, non-inferiority trial.Lancet Gastroenterol Hepatol · 202527 citationsRCR 9.1
- 23 citationsRCR 1.4
- Laparoscopic surgery contributes more to nutritional and immunologic recovery than fast-track care in colorectal cancer.World J Surg Oncol · 201520 citationsRCR 0.8
- 15 citationsRCR 0.4